Pirafene may be available in the countries listed below.
Ingredient matches for Pirafene
Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Pirafene in the following countries:
- Oman
International Drug Name Search
Pirafene may be available in the countries listed below.
Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Pirafene in the following countries:
International Drug Name Search
Aflozon may be available in the countries listed below.
Afloqualone is reported as an ingredient of Aflozon in the following countries:
International Drug Name Search
Norditropin
SimpleXx
5 mg/1.5 ml
solution for injection in cartridges
Somatropin
Keep this leaflet. You may need to read it again. If you have further questions, ask your doctor or pharmacist. This medicine has been prescribed for you personally. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Norditropin SimpleXx contains a biosynthetic human growth hormone called somatropin which is identical to the growth hormone produced naturally in the body. Children need growth hormone to help them grow, but adults also need it for their general health. Norditropin SimpleXx comes as a solution in a cartridge ready for you to inject after you have put it in the matching NordiPen injection pen.
In adults Norditropin SimpleXx is used to replace growth hormone if their growth hormone production has been decreased since childhood or has been lost in adulthood because of a tumour, treatment of a tumour or a disease that affects the gland which produces growth hormone.
Tell your doctor if any of these apply to you as Norditropin SimpleXx may not be suitable.
Your doctor needs to know if you are already being treated with:
Tell your doctor or pharmacist if you are taking other medicines or have recently taken any. This includes medicines obtained without a prescription.
Norditropin SimpleXx does not affect the use of any machines or the ability to drive safely.
Always use Norditropin SimpleXx exactly as your doctor has told you. Check with your doctor or pharmacist if you are unsure.
The dose for children depends on their body weight and body surface area. The adult dose depends on height, weight, gender and growth hormone sensitivity and will be adjusted until you are on the right dose.
Like all medicines, Norditropin SimpleXx can cause side effects, although not everybody gets them.
(may affect up to 1 in 10,000 people):
If you get any of these effects, see a doctor as soon as possible. Stop using Norditropin SimpleXx until your doctor says you can continue treatment.
Formation of antibodies directed against somatropin has been rarely observed during Norditropin therapy.
Cases of leukaemia and relapse of brain tumours have also been reported in patients treated with somatropin (the active ingredient in Norditropin SimpleXx), although there is no evidence that somatropin was responsible. If you think you are suffering from any of these diseases, speak to your doctor.
Uncommon effects
(may affect up to 1 in 100 children):
Rare effects
(may affect up to 1 in 1000 children):
In rare cases, children using Norditropin SimpleXx have experienced hip and knee pain or have started limping. These symptoms may be caused by a disease affecting the top of the thigh bone (Legg-Calvé disease) or because the end of the bone has slipped from the cartilage (slipped capital femoral epiphysis) and may not be due to Norditropin SimpleXx.
In children with Turner syndrome, a few cases of increased growth of hands and feet compared to height have been observed in clinical trials.
A clinical trial in children with Turner syndrome has shown that high doses of Norditropin can possibly increase the risk of getting ear infections.
Very common effects
(may affect more than 1 in 10 adults):
Common effects
(may affect up to 1 in 10 adults):
Uncommon effects
(may affect up to 1 in 100 adults):
If any of these side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist, as you may need to reduce your dose.
Keep out of the reach and sight of children. Do not use Norditropin SimpleXx after the expiry date which is stated on the package. The expiry date refers to the last day of that month.
Store unused Norditropin SimpleXx cartridges in a refrigerator (2°C to 8°C) in the outer carton, in order to protect from light. Do not freeze or expose to heat.
After starting to use a Norditropin SimpleXx 5 mg/1.5 ml cartridge in an injection pen you can either:
Do not continue to use Norditropin SimpleXx cartridges which have been frozen or exposed to excessive temperatures. Check each new Norditropin SimpleXx cartridge before you use it. Do not use any cartridge that is damaged or cracked.
Do not use any Norditropin SimpleXx cartridge if the solution inside is not clear and colourless.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Norditropin SimpleXx is a clear and colourless solution in a 1.5 ml glass cartridge ready for injection in the NordiPen injection pen.
1 ml of solution contains 3.3 mg somatropin.
1 mg of somatropin corresponds to 3 IU of somatropin.
Norditropin SimpleXx is available in three strengths:
5 mg/1.5 ml, 10 mg/1.5 ml and 15 mg/1.5 ml (equivalent to 3.3 mg/ml, 6.7 mg/ml and 10 mg/ml, respectively).
Norditropin SimpleXx is made by:
This leaflet was last approved in 02/2010.
Norditropin and SimpleXx are Trademarks owned by Novo Nordisk Health Care AG Switzerland
NordiPen is a trademark owned by Novo Nordisk A/S, Denmark
© 1999/2008
8-2070-01-002-4
Anti may be available in the countries listed below.
Aciclovir is reported as an ingredient of Anti in the following countries:
International Drug Name Search
Amantadin-neuraxpharm may be available in the countries listed below.
Amantadine sulfate (a derivative of Amantadine) is reported as an ingredient of Amantadin-neuraxpharm in the following countries:
International Drug Name Search
Acocontin may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Acocontin in the following countries:
International Drug Name Search
Codeine Phosphate Injection USP may be available in the countries listed below.
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codeine Phosphate Injection USP in the following countries:
International Drug Name Search